Continuous Glucose Monitoring Device Market: Emerging Trends Transforming Diabetes Care
Polaris Market Research releases its new research report on
the Continuous
Glucose Monitoring (CGM) Device market, which provides comprehensive
insight into the current market landscape and future outlook. It discusses all
the major forces that can help drive growth in the market. This report studies
the effect of rising demand, technology, applications, investments, and
competition. It offers a comprehensive insight into how the market is likely to
shape up in different market segments and geographies. Opportunities and
challenges that can affect the market in the future have been discussed.
Through both quantitative and qualitative analysis, this report helps market
players understand the factors influencing the market and its future growth
prospects.
Continuous Glucose Monitoring (CGM) Device Market at a
Glance
|
Market Metric |
Details |
|
Market Size, 2025 |
USD 13.73 billion |
|
Market Size, 2034 |
USD 50.21 billion |
|
CAGR, 2026–2034 |
15.5% |
|
Largest Segment and Share, 2025 |
Sensors, 48.63% share |
|
Fastest-Growing Segment and CAGR |
Transmitters & Receivers, 16.18% CAGR |
|
Leading Region and Share, 2025 |
North America, 41.28% share |
|
Fastest-Growing Region and CAGR |
Asia Pacific, 15.42% CAGR |
Understanding the Continuous Glucose Monitoring (CGM)
Device Market
Continuous glucose monitoring (CGM) devices are wearable
medical tools that track interstitial glucose levels in real time using a small
skin sensor, sending readings and trend alerts to a smartphone or receiver.
Rising diabetes prevalence and demand for digital, needle-free glucose tracking
are driving adoption of CGM sensors, transmitters, and insulin pump-integrated
systems worldwide.
What Are the Major Factors Influencing the Market?
The Continuous Glucose Monitoring (CGM) Device industry is
influenced by several factors that impact the demand, implementation,
investment, innovation, and competition in the market. This report discusses
the key forces that drive market growth and those that may bring opportunities
or restrict future development.
Key Growth Driver: Rising Prevalence of Diabetes
Rising global diabetes prevalence is fueling demand for
continuous glucose monitoring devices. The IDF Diabetes Atlas 2025 reports
roughly 589 million adults aged 20-79 living with diabetes worldwide, a figure
expected to reach 853 million by 2050, with 252 million cases still
undiagnosed. This growing disease burden is accelerating adoption of CGM
systems for real-time diabetes management.
Emerging Opportunity: Technological Advancements in
Glucose Monitoring
Advances in sensor accuracy and wear duration are widening
CGM adoption. Modern devices report Mean Absolute Relative Difference accuracy
of 8-11% and can now be worn for 14 to 15 days, reducing replacement frequency.
AI-driven predictive alerts flag impending high or low glucose levels, enabling
timely intervention and supporting broader use beyond insulin-dependent
patients.
Market Trend: Digital Health and Closed-Loop Integration
CGM systems are increasingly integrating with digital health
platforms, smartwatches, and closed-loop insulin delivery systems. Devices such
as the MiniMed 780G and Tandem Control-IQ+ use CGM readings to automatically
adjust insulin dosing, improving time-in-range outcomes. Growing use of CGM
data for wellness and non-diabetic metabolic tracking is further expanding the
addressable market.
Key Challenge: Inconsistent Reimbursement Policies
Reimbursement policies for CGM devices vary widely across
countries and insurers, slowing broader adoption. Coverage conditions,
prior-authorization requirements, and durable medical equipment criteria differ
between public and private payers, leading to higher out-of-pocket costs for
many patients. These inconsistencies delay access to advanced glucose
monitoring technology and limit market penetration in several regions.
ππ«π¨π°π¬π ππ¨π«π
ππ§π¬π’π π‘ππ¬:
https://www.polarismarketresearch.com/industry-analysis/continuous-glucose-monitoring-market
How Is AI Impacting the Continuous Glucose Monitoring
(CGM) Device Market?
AI has become increasingly relevant in different industries;
however, the impact of this technology largely depends on the particular
industry. This report provides an analysis of the effects of artificial
intelligence in the Continuous Glucose Monitoring (CGM) Device industry,
analyzing those applications of artificial intelligence which are pertinent to
the industry's products or services.
AI Impact Assessment:
AI improves real-time glucose pattern analysis, helping
detect variations early for better diabetes management. It generates
personalized insights from user data to trigger timely alerts and supports
predictive analytics that assist patients and clinicians in monitoring and
treatment decisions, strengthening the clinical value of continuous glucose
monitoring devices.
Which Market Segments Are Gaining Momentum?
The report offers an extensive analysis of the Continuous
Glucose Monitoring (CGM) Device market with respect to its major segments,
which include component type, indication, connectivity, end use, and
distribution channel. These segments are analyzed in the context of differences
that they have in terms of demand, adoption, application, revenues generated,
and growth opportunities. The report provides an understanding of changes in
terms of market preferences and demands. Segments that can provide growth opportunities
are also pointed out in this report.
What Is Happening Across Regional Markets?
In this report, we have provided an extensive geographical
analysis of the Continuous Glucose Monitoring (CGM) Device market, including
regions such as North America, Europe, Asia Pacific, Latin America, and the
Middle East & Africa. North America is leading in the market, owing to high
diabetes prevalence, well-established healthcare infrastructure, and strong
reimbursement policies that support CGM adoption. On the other hand, Asia
Pacific is projected to witness high growth during the forecast period due to
rising diabetes cases, increasing healthcare expenditure, and improving
awareness of advanced glucose monitoring solutions across China, India, and
Japan. In the regional analysis, the report has taken into account differences
in demand, investments, infrastructure, regulations, technology, industry
development, and maturity level in key geographies.
How Is the Competitive Landscape Changing?
The competitive landscape of the Continuous Glucose
Monitoring (CGM) Device market includes existing firms, new entrants, and
market-specific players. The study analyses the positioning strategies adopted
by companies based on their product/service innovations, alliances, mergers
& acquisitions, geographic presence, capacity expansions, and technological
advancements.
Key players covered in the report include:
Abbott Laboratories, Ascensia Diabetes Care Holdings AG,
DexCom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, Medtronic plc,
Menarini Diagnostics S.r.l., Nemaura Medical Inc., Senseonics Holdings, Inc.,
and Ypsomed AG.
Future Market Perspective
The Continuous
Glucose Monitoring (CGM) Device market is set to experience continued
growth through 2034, due to growing demand, widening applications, and
reactions from industry players based on changing market demands. Factors such
as innovation, investments, technology development, and increased opportunities
in various segments and regions are anticipated to shape the future of the
market. This report offers a forward-looking analysis of such trends, enabling
stakeholders to understand the possible evolution of the industry.
More Trending Latest Reports By Polaris Market Research:
solid-state-vs-semi-solid-ev-batteries-who-is-actually-shipping
strategic-positioning-of-top-10-companies-in-the-endoscopy-market-in-2025
personal-cooling-device-market
directed-energy-weapons-market
Comments
Post a Comment